Seattle-area biotech led by ex-Athira CEO Leen Kawas raises $35M for hepatitis D drug

EIT Pharma CEO Leen Kawas (EIT Pharma Photo) A Kirkland, Wash.-based biotech company led by former Athira Pharma CEO Leen Kawas has raised $35 million in a Series A round led by Propel Bio Partners , the Los Angeles investment firm where Kawas is a co-founder and managing general partner . EIT Pharma said Monday that the oversubscribed round also drew participation from Good Ventures, Arrowtown and others. The company said the money will support FDA review of lonafarnib, an oral treatment candid